קלופידקסל 75

国家: 以色列

语言: 希伯来文

来源: Ministry of Health

有效成分:

CLOPIDOGREL AS BESYLATE 75 MG

可用日期:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC代码:

B01AC04

药物剂型:

FILM COATED TABLETS

给药途径:

PER OS

厂商:

PHARMATHEN S.A., GREECE

治疗组:

CLOPIDOGREL

疗效迹象:

Clopidogrel is indicated for the prevention of atherothrombotic events as follows:• Recent MI, Recent stroke or Established peripheral arterial disease: Patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. For patients with a history of recent myocardial infarction (MI), recent stroke or established peripheral arterial disease, Clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new MI (fatal or not) and other vascular death.• Acute coronary syndrome: For patients with acute coronary syndrome (Non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave MI) or ST segment elevation acute myocardial infarction), in combination with ASA in medically treated patients eligible for thrombolytic therapy, and those who are to be managed with percutaneous coronary intervention (with or without stent) or CABG clopi

授权日期:

2010-09-01